PrEP

News
Gilead Sciences

Gilead's Descovy approved in HIV prophylaxis

The FDA has approved Gilead’s combination drug Descovy for HIV prophylaxis in the US, offering a way of cutting the risk of sexually acquired infection with an improved safety profile compa